MedDataX Logo

Activation of Alternative Cellular Energy (ACE) Pathway in the Therapy of Herpes Virus Infections

NCT ID: NCT00642785

Last Updated: 2008-06-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-01-31

Study Completion Date

2008-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The research question to be addressed is whether indirect phototherapy based activation of the body's alternative cellular energy (ACE) pathway will lead to expedited healing of active herpes simplex virus (HSV) and herpes zoster virus (HZV)skin lesions, and also possibly inhibit both latent HSV infections and residual HZV infections.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Herpes Simplex Herpes Zoster

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

herpes HSV zoster HZV shingles

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Patients with active oral or genital HSV skin lesions

No interventions assigned to this group

2

Patients with a history of recurrent oral or genital HSV but without an active lesion at the time of treatment

No interventions assigned to this group

3

Patients with active shingles/zoster

No interventions assigned to this group

4

Patients with post herpetic neuralgia

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of active, latent or residual HSV or HZV infection

Exclusion Criteria

* Unwilling or unable to provide Informed Consent
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institute of Progressive Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Institute of Progressive Medicine

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

W John Martin, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Institute of Progressive Medicine

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Martin WJ, Stoneburner J. Symptomatic relief of herpetic skin lesions utilizing an energy-based approach to healing. Exp Mol Pathol. 2005 Apr;78(2):131-4. doi: 10.1016/j.yexmp.2004.10.007. Epub 2005 Jan 5.

Reference Type BACKGROUND
PMID: 15713438 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

071/081

Identifier Type: -

Identifier Source: org_study_id